Articles tagged with Dulaglutide

Pharmac Proposes Wider Access to Type 2 Diabetes Medicines Based on Need

2 hours ago | 47 views

Associate Health Minister David Seymour and Health Minister Simeon Brown support Pharmac’s proposal to expand funding for three type 2 diabetes medicines by removing ethnicity-based criteria and lowering cardiovascular risk thresholds, aiming to improve access based on clinical need. If approved, the changes could benefit up to 23,000 more people over five years, enhancing early treatment to reduce complications and hospital admissions. This initiative aligns with the Government’s broader commitment to equitable, needs-based healthcare and increased health system funding to improve outcomes for all New Zealanders.

Tags: David Seymour Simeon Brown Pharmac type 2 diabetes empagliflozin liraglutide dulaglutide New Zealand health system Government